Zaza Mtine Ndhlovu, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
CD8-Positive T-Lymphocytes | 19 | 2022 | 4479 | 2.120 |
Why?
|
HIV-1 | 23 | 2024 | 6939 | 1.960 |
Why?
|
HIV Infections | 32 | 2024 | 16718 | 1.820 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 4 | 2018 | 222 | 1.300 |
Why?
|
Immunologic Memory | 4 | 2022 | 1348 | 1.200 |
Why?
|
Viral Load | 13 | 2020 | 3299 | 1.080 |
Why?
|
Coronavirus NL63, Human | 1 | 2024 | 4 | 0.970 |
Why?
|
CD4-Positive T-Lymphocytes | 5 | 2022 | 4386 | 0.810 |
Why?
|
AIDS Vaccines | 3 | 2020 | 938 | 0.780 |
Why?
|
HLA-B Antigens | 2 | 2018 | 353 | 0.690 |
Why?
|
Duodenum | 1 | 2022 | 483 | 0.660 |
Why?
|
HIV | 3 | 2022 | 1604 | 0.620 |
Why?
|
Measles virus | 4 | 2009 | 68 | 0.590 |
Why?
|
Measles Vaccine | 4 | 2009 | 76 | 0.520 |
Why?
|
Lymphocyte Activation | 3 | 2022 | 5524 | 0.500 |
Why?
|
Gene Products, gag | 2 | 2015 | 337 | 0.500 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2018 | 2540 | 0.480 |
Why?
|
Antibody Formation | 1 | 2018 | 1402 | 0.460 |
Why?
|
Antigens, Viral | 3 | 2019 | 1035 | 0.450 |
Why?
|
Th1 Cells | 1 | 2018 | 1057 | 0.450 |
Why?
|
Immunodominant Epitopes | 2 | 2015 | 267 | 0.450 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2017 | 1475 | 0.420 |
Why?
|
Immunologic Surveillance | 1 | 2012 | 93 | 0.420 |
Why?
|
HIV Antibodies | 1 | 2018 | 1322 | 0.390 |
Why?
|
Models, Immunological | 1 | 2012 | 527 | 0.360 |
Why?
|
Viremia | 3 | 2020 | 736 | 0.360 |
Why?
|
CD4 Lymphocyte Count | 3 | 2018 | 2559 | 0.340 |
Why?
|
Leukocytes, Mononuclear | 4 | 2024 | 1836 | 0.330 |
Why?
|
T-Lymphocytes | 3 | 2024 | 10180 | 0.320 |
Why?
|
Antigen Presentation | 2 | 2011 | 1284 | 0.320 |
Why?
|
Immunoglobulin G | 2 | 2018 | 4560 | 0.320 |
Why?
|
Blood | 1 | 2009 | 598 | 0.290 |
Why?
|
Measles | 4 | 2009 | 168 | 0.280 |
Why?
|
Antigen-Presenting Cells | 1 | 2009 | 973 | 0.260 |
Why?
|
Interferon-gamma | 5 | 2019 | 3206 | 0.240 |
Why?
|
Lymph Nodes | 3 | 2023 | 3474 | 0.210 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4751 | 0.210 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2022 | 91 | 0.210 |
Why?
|
Receptors, CXCR5 | 1 | 2022 | 92 | 0.210 |
Why?
|
Acute Disease | 5 | 2020 | 7149 | 0.200 |
Why?
|
T-Lymphocytes, Cytotoxic | 3 | 2020 | 1821 | 0.200 |
Why?
|
HLA-A2 Antigen | 3 | 2010 | 213 | 0.190 |
Why?
|
Cytokines | 3 | 2024 | 7322 | 0.180 |
Why?
|
Lymphocyte Count | 1 | 2022 | 793 | 0.170 |
Why?
|
Germinal Center | 1 | 2022 | 377 | 0.170 |
Why?
|
Interleukin-7 Receptor alpha Subunit | 1 | 2019 | 52 | 0.170 |
Why?
|
Zambia | 8 | 2009 | 261 | 0.160 |
Why?
|
Humans | 39 | 2024 | 744343 | 0.160 |
Why?
|
Enzyme-Linked Immunospot Assay | 2 | 2015 | 130 | 0.160 |
Why?
|
Kinetics | 2 | 2015 | 6473 | 0.140 |
Why?
|
Clone Cells | 1 | 2018 | 1692 | 0.130 |
Why?
|
Flow Cytometry | 2 | 2015 | 5974 | 0.120 |
Why?
|
History, 21st Century | 1 | 2020 | 1534 | 0.120 |
Why?
|
Mutation | 1 | 2018 | 29786 | 0.120 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1607 | 0.120 |
Why?
|
Cell Differentiation | 2 | 2022 | 11483 | 0.110 |
Why?
|
Transcriptional Activation | 1 | 2019 | 1783 | 0.110 |
Why?
|
Cell Communication | 1 | 2020 | 1621 | 0.110 |
Why?
|
History, 20th Century | 1 | 2020 | 2740 | 0.110 |
Why?
|
HLA-B27 Antigen | 1 | 2012 | 76 | 0.110 |
Why?
|
Viral Matrix Proteins | 2 | 2010 | 186 | 0.100 |
Why?
|
Adult | 14 | 2022 | 214055 | 0.100 |
Why?
|
Antibodies, Neutralizing | 1 | 2020 | 1978 | 0.090 |
Why?
|
Young Adult | 6 | 2020 | 56430 | 0.090 |
Why?
|
South Africa | 2 | 2017 | 1731 | 0.090 |
Why?
|
Female | 19 | 2022 | 380194 | 0.090 |
Why?
|
Gene Frequency | 1 | 2017 | 3588 | 0.090 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2016 | 1366 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2183 | 0.090 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2886 | 0.090 |
Why?
|
Anti-Retroviral Agents | 1 | 2019 | 1715 | 0.090 |
Why?
|
Cross Reactions | 1 | 2011 | 841 | 0.080 |
Why?
|
RNA, Viral | 2 | 2015 | 2902 | 0.080 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6489 | 0.080 |
Why?
|
HLA-A Antigens | 1 | 2009 | 231 | 0.080 |
Why?
|
Male | 15 | 2022 | 350118 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 2988 | 0.080 |
Why?
|
B-Lymphocytes | 1 | 2022 | 4665 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 1434 | 0.080 |
Why?
|
Lymphocytes | 1 | 2016 | 2617 | 0.080 |
Why?
|
Hemagglutinins, Viral | 1 | 2007 | 67 | 0.080 |
Why?
|
Adenoviridae | 1 | 2011 | 1099 | 0.070 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2007 | 66 | 0.070 |
Why?
|
Species Specificity | 1 | 2011 | 2478 | 0.070 |
Why?
|
Amino Acid Sequence | 1 | 2018 | 13815 | 0.070 |
Why?
|
Intestines | 1 | 2016 | 1924 | 0.070 |
Why?
|
Immunoglobulins | 1 | 2010 | 881 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 6171 | 0.070 |
Why?
|
Alleles | 1 | 2017 | 6933 | 0.070 |
Why?
|
Immunoassay | 1 | 2009 | 752 | 0.070 |
Why?
|
Cells, Cultured | 4 | 2017 | 19229 | 0.060 |
Why?
|
Epitopes, T-Lymphocyte | 3 | 2017 | 880 | 0.060 |
Why?
|
Adolescent | 7 | 2020 | 85781 | 0.060 |
Why?
|
Cell Proliferation | 1 | 2019 | 10481 | 0.060 |
Why?
|
Massachusetts | 1 | 2015 | 8663 | 0.050 |
Why?
|
Apoptosis | 2 | 2016 | 9727 | 0.050 |
Why?
|
Proviruses | 1 | 2024 | 318 | 0.050 |
Why?
|
Time Factors | 6 | 2016 | 40075 | 0.050 |
Why?
|
Anti-HIV Agents | 1 | 2017 | 4256 | 0.050 |
Why?
|
Antibodies, Viral | 4 | 2022 | 3176 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16365 | 0.050 |
Why?
|
Genetic Vectors | 1 | 2011 | 3420 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2018 | 19905 | 0.050 |
Why?
|
Sex Distribution | 2 | 2004 | 2297 | 0.050 |
Why?
|
Disease Progression | 1 | 2017 | 13284 | 0.050 |
Why?
|
Age Distribution | 2 | 2004 | 2902 | 0.050 |
Why?
|
Acute-Phase Reaction | 1 | 2020 | 91 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2012 | 0.040 |
Why?
|
DNA Methylation | 1 | 2013 | 4286 | 0.040 |
Why?
|
Dendritic Cells | 1 | 2010 | 2725 | 0.040 |
Why?
|
Systems Integration | 1 | 2020 | 440 | 0.040 |
Why?
|
Disease Outbreaks | 2 | 1998 | 1772 | 0.040 |
Why?
|
Peptides | 1 | 2010 | 4409 | 0.040 |
Why?
|
DNA, Viral | 1 | 2024 | 2225 | 0.040 |
Why?
|
Virus Replication | 2 | 2016 | 2534 | 0.030 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2016 | 1873 | 0.030 |
Why?
|
Phylogeny | 1 | 2023 | 2803 | 0.030 |
Why?
|
Risk-Taking | 1 | 2001 | 986 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2571 | 0.030 |
Why?
|
Infant | 5 | 2009 | 35136 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 14722 | 0.030 |
Why?
|
Base Sequence | 1 | 2024 | 12797 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2020 | 13989 | 0.030 |
Why?
|
Perforin | 1 | 2012 | 168 | 0.030 |
Why?
|
HIV Long-Term Survivors | 1 | 2012 | 126 | 0.030 |
Why?
|
Sexual Behavior | 1 | 2001 | 2057 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2020 | 1708 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2017 | 4320 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2020 | 2133 | 0.020 |
Why?
|
Middle Aged | 4 | 2012 | 213383 | 0.020 |
Why?
|
Immunoglobulin Isotypes | 1 | 2009 | 158 | 0.020 |
Why?
|
Antibody Affinity | 1 | 2009 | 254 | 0.020 |
Why?
|
Endemic Diseases | 1 | 2009 | 182 | 0.020 |
Why?
|
Animals | 1 | 2020 | 168757 | 0.020 |
Why?
|
Sentinel Surveillance | 2 | 2001 | 281 | 0.020 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 7785 | 0.020 |
Why?
|
Pregnancy Complications, Infectious | 1 | 1998 | 2026 | 0.020 |
Why?
|
Child, Preschool | 2 | 2009 | 41006 | 0.020 |
Why?
|
Immunization, Secondary | 1 | 2007 | 340 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2016 | 2958 | 0.010 |
Why?
|
Gene Expression | 1 | 2017 | 7799 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9438 | 0.010 |
Why?
|
Cell Movement | 1 | 2016 | 5217 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2016 | 2987 | 0.010 |
Why?
|
United States | 1 | 2011 | 69872 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5867 | 0.010 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2008 | 1320 | 0.010 |
Why?
|
Chronic Disease | 1 | 2016 | 9146 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2013 | 7722 | 0.010 |
Why?
|
Prevalence | 3 | 2001 | 15226 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 12072 | 0.010 |
Why?
|
AIDS Serodiagnosis | 1 | 1998 | 184 | 0.010 |
Why?
|
Vaccination | 1 | 2009 | 3278 | 0.010 |
Why?
|
Sampling Studies | 1 | 1998 | 623 | 0.010 |
Why?
|
Child | 1 | 2004 | 77709 | 0.010 |
Why?
|
Saliva | 1 | 1998 | 809 | 0.010 |
Why?
|
Cohort Studies | 1 | 2016 | 40561 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 53288 | 0.010 |
Why?
|
Demography | 1 | 1997 | 1656 | 0.010 |
Why?
|
Prenatal Care | 1 | 1998 | 1092 | 0.010 |
Why?
|
Educational Status | 1 | 1998 | 2540 | 0.010 |
Why?
|
Urban Population | 1 | 1998 | 2021 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2016 | 63114 | 0.010 |
Why?
|
Rural Population | 1 | 1998 | 2210 | 0.000 |
Why?
|
Risk Factors | 1 | 2008 | 72290 | 0.000 |
Why?
|
Age Factors | 1 | 1997 | 18370 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2001 | 39050 | 0.000 |
Why?
|
Pregnancy | 1 | 1998 | 29144 | 0.000 |
Why?
|